AU2005273726A1 - Arene ruthenium (II) compounds and their use in cancer therapy - Google Patents

Arene ruthenium (II) compounds and their use in cancer therapy Download PDF

Info

Publication number: AU2005273726A1
Authority: AU; Australia
Prior art keywords: compound according; alkyl; carbocyclic; compound; group
Prior art date: 2004-08-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2005273726A

Other languages

English (en)

Inventor

Abraha Habtemariam

Peter John Sadler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Edinburgh

Original Assignee

University of Edinburgh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-20

Filing date

2005-08-19

Publication date

2006-02-23

2005-08-19 Application filed by University of Edinburgh filed Critical University of Edinburgh

2006-02-23 Publication of AU2005273726A1 publication Critical patent/AU2005273726A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU2005273726A 2004-08-20 2005-08-19 Arene ruthenium (II) compounds and their use in cancer therapy Abandoned AU2005273726A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0418643.3		2004-08-20
GBGB0418643.3A GB0418643D0 (en)	2004-08-20	2004-08-20	Ruthenium (II) compounds
PCT/GB2005/003242 WO2006018649A1 (fr)	2004-08-20	2005-08-19	Composes arene-ruthenium (ii) et leur utilisation dans la therapie du cancer.

Publications (1)

Publication Number	Publication Date
AU2005273726A1 true AU2005273726A1 (en)	2006-02-23

Family

ID=33042406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2005273726A Abandoned AU2005273726A1 (en)	2004-08-20	2005-08-19	Arene ruthenium (II) compounds and their use in cancer therapy

Country Status (12)

Country	Link
EP (1)	EP1786412A1 (fr)
JP (1)	JP2008510693A (fr)
KR (1)	KR20070060091A (fr)
CN (1)	CN101043885A (fr)
AU (1)	AU2005273726A1 (fr)
BR (1)	BRPI0514430A (fr)
CA (1)	CA2578280A1 (fr)
GB (1)	GB0418643D0 (fr)
MX (1)	MX2007002099A (fr)
NO (1)	NO20071481L (fr)
WO (1)	WO2006018649A1 (fr)
ZA (1)	ZA200702093B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006017594A1 (de) *	2006-04-13	2007-10-18	Wacker Chemie Ag	Neuartige Ru-Komplexe, deren Herstellung und Verwendung
WO2007128158A1 (fr)	2006-05-09	2007-11-15	Ecole Polytechnique Federale De Lausanne (Epfl)	COMPLEXES DE MÉTAUX DE TRANSITION PERMETTANT d'INHIBER LA RÉSISTANCE DANS LE TRAITEMENT DU CANCER ET DES MÉTASTASES
GB0711849D0 (en)	2007-06-19	2007-07-25	Oxford Biosensors Ltd	Redox Mediators
EP2067771A1 (fr)	2007-12-03	2009-06-10	EPFL Ecole Polytechnique Fédérale de Lausanne	Dérivés de Dihydroxypyrrolidine en tant que composés anti-cancéreux
EP2409697A1 (fr)	2010-07-20	2012-01-25	Université de Neuchâtel	Médicaments basés sur des complexes dinucléaires de ruthénium, osmium et fer comprenant des ligands à triple pont thiolato, sélénato, alkoxo et/ou amido
WO2013038395A1 (fr)	2011-09-16	2013-03-21	Universidade De Lisboa	Complexes de métaux de transition pour applications pharmaceutiques
WO2013136296A2 (fr)	2012-03-14	2013-09-19	Universidade De Lisboa	Composés de ruthénium et de fer organométalliques solubles dans l'eau présentant des ligands hétéroaromatiques
RU2682674C2 (ru)	2013-03-15	2019-03-20	Шерри Энн МАКФАРЛЭНД	Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение
US9751081B2 (en)	2014-12-01	2017-09-05	Clemson University	Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19736152A1 (de) *	1997-08-14	1999-02-18	Martin Wehlan	Azido-Aziridinkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE303393T1 (de) *	1999-10-27	2005-09-15	Univ Court The University Of E	Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
GB0016052D0 (en) *	2000-06-30	2000-08-23	Univ Edinburgh	Ruthenium (II) compounds
GB0215526D0 (en) *	2002-07-05	2002-08-14	Univ Edinburgh	Anticancer compounds

2004
- 2004-08-20 GB GBGB0418643.3A patent/GB0418643D0/en not_active Ceased
2005
- 2005-08-19 AU AU2005273726A patent/AU2005273726A1/en not_active Abandoned
- 2005-08-19 JP JP2007526570A patent/JP2008510693A/ja active Pending
- 2005-08-19 EP EP05771813A patent/EP1786412A1/fr not_active Withdrawn
- 2005-08-19 WO PCT/GB2005/003242 patent/WO2006018649A1/fr not_active Ceased
- 2005-08-19 CA CA002578280A patent/CA2578280A1/fr not_active Abandoned
- 2005-08-19 BR BRPI0514430-2A patent/BRPI0514430A/pt not_active IP Right Cessation
- 2005-08-19 KR KR1020077006364A patent/KR20070060091A/ko not_active Withdrawn
- 2005-08-19 MX MX2007002099A patent/MX2007002099A/es not_active Application Discontinuation
- 2005-08-19 CN CNA2005800355417A patent/CN101043885A/zh active Pending
2007
- 2007-03-12 ZA ZA200702093A patent/ZA200702093B/xx unknown
- 2007-03-20 NO NO20071481A patent/NO20071481L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200702093B (en)	2008-08-27
JP2008510693A (ja)	2008-04-10
NO20071481L (no)	2007-05-16
EP1786412A1 (fr)	2007-05-23
MX2007002099A (es)	2007-04-24
GB0418643D0 (en)	2004-09-22
KR20070060091A (ko)	2007-06-12
BRPI0514430A (pt)	2008-05-06
CA2578280A1 (fr)	2006-02-23
CN101043885A (zh)	2007-09-26
WO2006018649A1 (fr)	2006-02-23

Publication	Publication Date	Title
EP1991556A1 (fr)	2008-11-19	Composes comprenant du ruthenium (ii)
KR101059183B1 (ko)	2011-08-25	피롤로벤조디아제핀
EP2146977B1 (fr)	2012-11-14	Synthèse de carbonates cycliques en présence de catalyseurs d'aluminium (salen) dimère
AU2005273726A1 (en)	2006-02-23	Arene ruthenium (II) compounds and their use in cancer therapy
EP2445915B1 (fr)	2016-04-20	Composés 3h-imidazo[5,1-d][1,2,3,5-tétrazin-4-one 3-substitués-8-substitués et leur utilisation
US20090186864A1 (en)	2009-07-23	Ruthenium (ii) compounds
Khalid et al.	2022	Structure and surface analyses of a newly synthesized acyl thiourea derivative along with its in silico and in vitro investigations for RNR, DNA binding, urease inhibition and radical scavenging activities
US20080096846A1 (en)	2008-04-24	Arene Ruthenium (ll) Compounds And Their Use In Cancer Therapy
JP6985764B2 (ja)	2021-12-22	アミノピリミジン系化合物、この化合物を含む組成物およびそれらの使用
Pörschke	1987	Coupling of Two Ethyne Molecules at a Nickel Center to Form a Nickelacyclopentadiene Complex
JP5722234B2 (ja)	2015-05-20	抗がん剤の製造方法
WO2010024783A1 (fr)	2010-03-04	Composés de biarylrhodanine et de pyridylrhodanine et leur utilisation
JP5015451B2 (ja)	2012-08-29	ホスフィン遷移金属錯体、その製造方法およびそれを含有する抗癌剤
JP5646606B2 (ja)	2014-12-24	抗がん剤の製造方法
AU2004238625A1 (en)	2004-11-25	Glyoxalase inhibitors
JP5722233B2 (ja)	2015-05-20	抗がん剤の製造方法
Erker et al.	1992	Structures and dynamic features of dinuclear tartratozirconocene complexes
Lim et al.	1997	Palladium (II) and platinum (II) complexes containing dimesyloxy-substituted chiral diamines
Can	2012	An Approach Towards Theragnostic Receptor Targeting with 5-Cyclopentadienyl Derivatives of the fac-{99mTc (CO) 3}-and fac-{Re (CO) 3}-Core

Legal Events

Date	Code	Title	Description
2011-03-17	MK4	Application lapsed section 142(2)(d) - no continuation fee paid for the application